HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract.

AbstractPURPOSE:
The purpose of this trial was to evaluate an immunoassay for urinary nuclear matrix protein, NMP22, as an indicator for transitional cell carcinoma of the urinary tract.
MATERIALS AND METHODS:
Three groups of subjects participated in this trial of NMP22: 1-175 with transitional cell carcinoma, 2-117 with benign urinary tract conditions and 3-375 healthy volunteers. Each subject provided a single (3 voids) urine sample for analysis at the time of study entry. Each sample was assayed for the level of NMP22.
RESULTS:
In normal healthy volunteers and in subjects with benign conditions median NMP22 levels were 2.9 and 3.3 units per ml., respectively. Median urinary NMP22 levels in patients with transitional cell carcinoma were significantly greater than in comparison subjects. Patients with active transitional cell carcinoma had significantly greater median urinary NMP22 levels than those with no evidence of disease (6.04 versus 4.11 units per ml., p = 0.027, 1-tailed Mann-Whitney U test). We noted no effect of tumor grade, extent of disease or exposure to intravesical therapy on urinary NMP22 levels.
CONCLUSIONS:
NMP22 is a promising urinary tumor marker for monitoring transitional cell carcinoma. Nuclear matrix proteins are a new class of tumor markers that represent the basis for the development of assays with increased efficacy for the detection and treatment of cancer.
AuthorsG A Carpinito, W M Stadler, J V Briggman, G W Chodak, P A Church, D L Lamm, P H Lange, E M Messing, R M Pasciak, G B Reservitz, R N Ross, D B Rukstalis, M F Sarosdy, M S Soloway, R P Thiel, N Vogelzang, C L Hayden
JournalThe Journal of urology (J Urol) Vol. 156 Issue 4 Pg. 1280-5 (Oct 1996) ISSN: 0022-5347 [Print] United States
PMID8808854 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Nuclear Proteins
  • nuclear matrix protein 22
Topics
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (urine)
  • Carcinoma, Transitional Cell (pathology, therapy, urine)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nuclear Proteins (urine)
  • Prospective Studies
  • Urologic Neoplasms (pathology, therapy, urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: